# Mineralys Therapeutics, Inc.: Form 8-K, filed Mar 10, 2025

- Company: [Mineralys Therapeutics, Inc.](/companies/mlys.md) (CIK 1933414)
- Form: 8-K
- Filed: 2025-03-10
- Accepted by EDGAR: Mar 10, 2025, 07:05 ET
- Period: 2025-03-10
- Accession: 0001628280-25-011459
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1933414/000162828025011459/mlys-20250310.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1933414/000162828025011459/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1933414/000162828025011459/mlys-20250310.htm

Filed Mar 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-011459. Last ingested by Listed: Nov 4, 2026, 19:22 ET. No prices; not investment advice.